SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (28343)5/21/1998 11:00:00 AM
From: eddie r gammon  Read Replies (1) | Respond to of 132070
 
Mike from an investment point of view do you think LGND may be dead in the water for a little while. I base the question on the fact that I think most investor were betting on a big cancer announcement. Now it looks like several other companies have beat them to the punch. I know they still could come up with a diabetes announcement or some other in their pipeline but I get the feeling it may just lay here for a while.

erg



To: Knighty Tin who wrote (28343)5/21/1998 4:47:00 PM
From: Stephen L. Smith  Read Replies (1) | Respond to of 132070
 
Michael -- I'm a relatively new lurker to this thread, so if you have commented on this previously, forgive me. Do you have an opinion on BIOI? Thanks Steve Smith



To: Knighty Tin who wrote (28343)5/22/1998 10:25:00 AM
From: Cardin Drake  Respond to of 132070
 
Michael, thanks for the list. I really think the biotechs as a group are going to cure cancer, but investing in them is definitely swimming in shark-filled waters. I may stick with the mutual fund for now, although, despite the hype, I think Entremed may be on to something.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News